113 related articles for article (PubMed ID: 2447926)
1. Pulmonary toxicity after treatment with bleomycin alone or in combination with hyperoxia. Studies in the rat.
Blom-Muilwijk MC; Vriesendorp R; Veninga TS; Hofstra W; Sleyfer DT; Wieringa RA; Konings AW
Br J Anaesth; 1988 Jan; 60(1):91-7. PubMed ID: 2447926
[TBL] [Abstract][Full Text] [Related]
2. Absence of an additional fibrotic response caused by oxygen in the lungs of rats after the intratracheal administration of bleomycin.
Veninga TS; Vriesendorp R; Blom-Muilwijk MC; Sleyfer DT; Konings AW
Br J Anaesth; 1988 Oct; 61(4):413-8. PubMed ID: 2461215
[TBL] [Abstract][Full Text] [Related]
3. Differences in effects of immediate and delayed hyperoxia exposure on bleomycin-induced pulmonary injury.
Tryka AF; Godleski JJ; Brain JD
Cancer Treat Rep; 1984 May; 68(5):759-64. PubMed ID: 6202406
[TBL] [Abstract][Full Text] [Related]
4. Adaptation to chronic hyperoxia. Biochemical effects and the response to subsequent lethal hyperoxia.
Coursin DB; Cihla HP; Will JA; McCreary JL
Am Rev Respir Dis; 1987 May; 135(5):1002-6. PubMed ID: 3579000
[TBL] [Abstract][Full Text] [Related]
5. In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats.
Serrano-Mollar A; Closa D; Prats N; Blesa S; Martinez-Losa M; Cortijo J; Estrela JM; Morcillo EJ; Bulbena O
Br J Pharmacol; 2003 Mar; 138(6):1037-48. PubMed ID: 12684259
[TBL] [Abstract][Full Text] [Related]
6. Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats.
Hay JG; Haslam PL; Dewar A; Addis B; Turner-Warwick M; Laurent GJ
Thorax; 1987 May; 42(5):374-82. PubMed ID: 2443992
[TBL] [Abstract][Full Text] [Related]
7. Failure of systemic N-acetyl cysteine to protect the rat lung against bleomycin toxicity.
Ward HE; Nicholson A; Berend N
Pathology; 1987 Oct; 19(4):358-60. PubMed ID: 2451202
[TBL] [Abstract][Full Text] [Related]
8. [Effect of intra-amniotic endotoxin priming plus hyperoxic exposure on the expression of vascular endothelial growth factor and its receptors in lungs of preterm newborn rats].
Wang W; Wei W; Ning Q; Luo XP
Zhonghua Er Ke Za Zhi; 2007 Jul; 45(7):533-8. PubMed ID: 17953812
[TBL] [Abstract][Full Text] [Related]
9. The effect of bleomycin and oxygen on rat lung.
Berend N
Pathology; 1984 Apr; 16(2):136-9. PubMed ID: 6205354
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of bleomycin-induced lung fibrosis in rats by mesna.
El-Medany A; Hagar HH; Moursi M; At Muhammed R; El-Rakhawy FI; El-Medany G
Eur J Pharmacol; 2005 Feb; 509(1):61-70. PubMed ID: 15713430
[TBL] [Abstract][Full Text] [Related]
11. Deferoxamine infusion does not inhibit bleomycin-induced lung damage in the rat.
Ward HE; Hicks M; Nicholson A; Berend N
Am Rev Respir Dis; 1988 Jun; 137(6):1356-9. PubMed ID: 2462374
[TBL] [Abstract][Full Text] [Related]
12. N-acetylcysteine does not protect against type II cell injury after prolonged exposure to hyperoxia in rats.
van Klaveren RJ; Dinsdale D; Pype JL; Demedts M; Nemery B
Am J Physiol; 1997 Sep; 273(3 Pt 1):L548-55. PubMed ID: 9316488
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of tallysomycin toxicity in rats by concurrent exposure to sublethal hyperoxia.
Coursin DB; Cihla HP; Oberley TD
Toxicology; 1989 Apr; 55(1-2):225-37. PubMed ID: 2469139
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of hypoxia on bleomycin lung toxicity in the rat.
Berend N
Am Rev Respir Dis; 1984 Aug; 130(2):307-8. PubMed ID: 6205617
[TBL] [Abstract][Full Text] [Related]
15. Increased lung copper-zinc-superoxide dismutase activity and absence of magnetic resonance imaging-detectable lung damage in copper-deficient rats exposed to hyperoxia.
Taylor CG; Bray TM
J Nutr; 1991 Apr; 121(4):467-73. PubMed ID: 2007900
[TBL] [Abstract][Full Text] [Related]
16. Effects of exercise on bleomycin-induced pulmonary toxicity in mice.
Stone DW; Copelan EA; Weisbrode SE; Rozmiarek H
Cancer Treat Rep; 1986 Sep; 70(9):1067-71. PubMed ID: 2427195
[TBL] [Abstract][Full Text] [Related]
17. [The effect of foamy alveolar macrophages presented in bleomycin-injured rat lungs in pulmonary fibrosis].
Suwabe A; Nakamura H; Yakuwa N; Igarashi K; Higuchi J; Takahashi K; Yasui S
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):3-13. PubMed ID: 2473235
[TBL] [Abstract][Full Text] [Related]
18. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta.
Kalayarasan S; Sriram N; Sudhandiran G
Life Sci; 2008 Jun; 82(23-24):1142-53. PubMed ID: 18462759
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant enzyme activity in alveolar type II cells after exposure of rats to hyperoxia.
Freeman BA; Mason RJ; Williams MC; Crapo JD
Exp Lung Res; 1986; 10(2):203-22. PubMed ID: 3007082
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
Verma R; Brahmankar M; Kushwah L; Suresh B
Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
